241 related articles for article (PubMed ID: 33727696)
41. Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype "Acral FibroChondroMyxoid Tumors".
Bouvier C; Le Loarer F; Macagno N; Aubert S; Audard V; Geneste D; Gomez-Brouchet A; Guinebretière JM; Larousserie F; Pissaloux D; Marie B; Tirode F; Baud J; De Pinieux G
Mod Pathol; 2020 Jul; 33(7):1360-1368. PubMed ID: 32047233
[TBL] [Abstract][Full Text] [Related]
42. Fusion of Platelet Derived Growth Factor Receptor Alpha (
Panagopoulos I; Andersen K; Gorunova L; Lobmaier I
Cancer Genomics Proteomics; 2024; 21(3):252-259. PubMed ID: 38670591
[TBL] [Abstract][Full Text] [Related]
43. Emerging soft tissue tumors with kinase fusions: An overview of the recent literature with an emphasis on diagnostic criteria.
Antonescu CR
Genes Chromosomes Cancer; 2020 Aug; 59(8):437-444. PubMed ID: 32243019
[TBL] [Abstract][Full Text] [Related]
44. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis.
Xu B; Chang K; Folpe AL; Kao YC; Wey SL; Huang HY; Gill AJ; Rooper L; Bishop JA; Dickson BC; Lee JC; Antonescu CR
Am J Surg Pathol; 2020 Jun; 44(6):729-737. PubMed ID: 31934916
[TBL] [Abstract][Full Text] [Related]
45. Cartilage- and bone-forming tumors of the soft tissues.
Reiman HM; Dahlin DC
Semin Diagn Pathol; 1986 Nov; 3(4):288-305. PubMed ID: 3303235
[TBL] [Abstract][Full Text] [Related]
46. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
47. Novel NTRK3 Fusions in Fibrosarcomas of Adults.
Yamazaki F; Nakatani F; Asano N; Wakai S; Sekimizu M; Mitani S; Kubo T; Kawai A; Ichikawa H; Yoshida A
Am J Surg Pathol; 2019 Apr; 43(4):523-530. PubMed ID: 30520818
[TBL] [Abstract][Full Text] [Related]
48. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
49. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
[TBL] [Abstract][Full Text] [Related]
50. Myxoid Spindle Cell Sarcoma With
So YK; Chow C; To KF; Chan JKC; Cheuk W
Int J Surg Pathol; 2020 Aug; 28(5):574-578. PubMed ID: 32050835
[TBL] [Abstract][Full Text] [Related]
51. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
52. Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma.
Pfeifer A; Rusinek D; Żebracka-Gala J; Czarniecka A; Chmielik E; Zembala-Nożyńska E; Wojtaś B; Gielniewski B; Szpak-Ulczok S; Oczko-Wojciechowska M; Krajewska J; Polańska J; Jarząb B
Genes Chromosomes Cancer; 2019 Aug; 58(8):558-566. PubMed ID: 30664823
[TBL] [Abstract][Full Text] [Related]
53. Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.
Al-Ibraheemi A; Folpe AL; Perez-Atayde AR; Perry K; Hofvander J; Arbajian E; Magnusson L; Nilsson J; Mertens F
Mod Pathol; 2019 Mar; 32(3):423-434. PubMed ID: 30310176
[TBL] [Abstract][Full Text] [Related]
54. Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes.
Acosta AM; Sholl LM; Dickson BC; McKenney JK; Gordetsky JB; Pins MR; Marino-Enriquez A; Dong F; Dubuc AM; Cin PD; Fletcher CDM
Mod Pathol; 2021 Sep; 34(9):1763-1779. PubMed ID: 33986460
[TBL] [Abstract][Full Text] [Related]
55. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
[TBL] [Abstract][Full Text] [Related]
56. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
[TBL] [Abstract][Full Text] [Related]
57. A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Fletcher CD; Antonescu CR
Genes Chromosomes Cancer; 2020 Jun; 59(6):348-356. PubMed ID: 31994243
[TBL] [Abstract][Full Text] [Related]
58. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
[TBL] [Abstract][Full Text] [Related]
59. Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer.
Xia H; Xue X; Ding H; Ou Q; Wu X; Nagasaka M; Shao YW; Hu X; Ou SI
Clin Lung Cancer; 2020 May; 21(3):247-254. PubMed ID: 31761448
[TBL] [Abstract][Full Text] [Related]
60. Identification of NTRK fusions in pediatric mesenchymal tumors.
Pavlick D; Schrock AB; Malicki D; Stephens PJ; Kuo DJ; Ahn H; Turpin B; Allen JM; Rosenzweig M; Badizadegan K; Ross JS; Miller VA; Wong V; Ali SM
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
